What changes when the right expertise arrives early.

Qualira assessed an ongoing medical-device clinical study, completed a gap analysis, applied corrective measures, and then continued with clinical trial management including operating procedures and documentation systems.

For a novel device, Qualira recommended a 513(g) followed by a Pre-Submission. FDA recommended De Novo rather than PMA, and then agreed the team could move forward with animal study data rather than an IDE clinical trial.

After a customer audit uncovered nonconformances, Qualira designed and helped implement a quality management system suitable for the small medical-device company's operations.

Qualira designed and implemented a quality system for a surgical-device manufacturer, then continued daily quality and regulatory support including CAPA, supplier evaluation, nonconforming product control, ECR implementation, and document control.

When an implant company faced setbacks from prior consultants, Qualira completed on-site DHF remediation and QMS compliance within three months. The client then obtained 510(k) clearance and launched commercialization.

After an FDA inspection and 483, Qualira drafted a response accepted without additional requirements on the proposed corrective actions, then supported three recalls through health-risk assessment and documentation.

Qualira developed regulatory strategy and testing plans for dental-lab aligners, supported Traditional 510(k) submissions, and addressed FDA questions to help clients achieve clearance.